Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuoTrav APS vs DuoTrav in Glaucoma and Ocular Hypertension
NCT00862472Phase 3Withdrawn
- Sponsor
- Alcon Inc.
- Start
- Mar 2009
- Primary completion
- Jun 2009
01
Overview
A Phase 3 trial of travoprost + timolol in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Planned start Mar 2009; status: withdrawn.
02
Drugs
travoprost + timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00862472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00862472.